ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)
LightNews LightNews
advance-id.bsky.social
ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)
@advance-id.bsky.social
100 followers 120 following 34 posts
A global network for infectious disease clinical studies.

#AMR #InfectiousDiseases #ADVANCE_ID #AntimicrobialResistance #Research #NUS #Singapore
Posts Replies Media Videos
advance-id.bsky.social
✨ We’re are pleased to introduce Dr Xiao Tingting and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
November 19, 2025 at 2:14 AM
advance-id.bsky.social
Join us on 8–9 Dec 2025 for the REACH Asia Forum on Community Engagement! Hear from experts and community leaders across the region on strengthening community engagement and participation in health research.

Register at 🔗https://ad-id.co/reach2025

#CommunityEngagement
November 12, 2025 at 5:52 AM
advance-id.bsky.social
We’re delighted to share highlights from our recent workshop “Framing JUST solutions for ACCESS to treatment against AMR”! Fantastic participants, candid challenge-sharing, and lively, solutions-focused discussions throughout the day.
Read more: ad-id.co/4qMQMb1
November 7, 2025 at 6:22 AM
advance-id.bsky.social
🧪 Share Your #AMR Research at #ACC2026 now! Abstract Submission Open Until 14 Nov 2025.

Organized by @gardp.bsky.social , @bsacandjac.bsky.social , @advance-id.bsky.social & Mahidol University.

🗓 Submission deadline: Friday, 14 Nov 2025
🔗 Submit your abstract: lnkd.in/dBfh3zWJ

#AbstractSubmission
November 5, 2025 at 1:20 AM
advance-id.bsky.social
New research led by Dr Mo Yin from ADVANCE-ID (NUS) finds that some individuals can carry multidrug-resistant E. coli for extended periods and at high amounts, potentially spreading it.

Find out more:
Lianhe Zaobao: ad-id.co/3Jtm9GO
NUS Medicine: ad-id.co/3LclQ3H
October 30, 2025 at 7:08 AM
advance-id.bsky.social
What do you think are the overlooked priorities in antimicrobial resistance mitigation strategies? Share your top 3:

Link: forms.office.com/r/CP81tasyRX
⏱ Takes <3 minutes

@ttu.edu #GodwinPiusOhemu
October 23, 2025 at 1:13 AM
advance-id.bsky.social
Proud to join @who.int ’s new GCTF to advance equitable, ethical & impactful research worldwide. Together with NUS SSHSPH, ADVANCE-ID will help strengthen Asia’s trial ecosystems - training local teams, innovating designs & fostering collaboration.

🔗 Read more: ad-id.co/GCTF
October 8, 2025 at 5:15 AM
advance-id.bsky.social
NUS Medicine has received a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support DETECT-Asia (Strengthening Diagnostics for sEvere bacTErial infeCTions in Asia) to enhance the #diagnostics for severe bacterial infections and fight #AMR. ad-id.co/gpr
October 2, 2025 at 10:12 AM
advance-id.bsky.social
ADVANCE-ID Directors make presentations at the inaugural Global AMR Innovators Conference (GAMRIC), London, October 1 and 2, 2025.

Read more: ad-id.co/a1

#GAMRIC2025
October 2, 2025 at 9:08 AM
advance-id.bsky.social
🌍 Passionate about Clinical Microbiology & #AMR? Join us in our #Microbiology Interest Group! We would love to connect with #microbiologists, ID physicians, fellows, lab staff & managers - All levels of experience are welcome!

📩 Contact Dr Alec Aligui: alec.aligui@u.nus.edu

#physicians #clinical
September 24, 2025 at 2:50 AM
advance-id.bsky.social
✨ We’re excited to have Dr Xiong Beibei join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
September 17, 2025 at 2:39 AM
advance-id.bsky.social
✨ We’re excited to have Dr Nguyen Thi Kim Anh join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
September 10, 2025 at 2:09 AM
advance-id.bsky.social
🚨Last week to comment! WHO’s draft TPPs for new antibacterial agents are open for public consultation until 7 Sep 2025. Feedback is particularly encouraged on the special considerations for children in TPPs 2 & 3.

Share your input: bit.ly/3JPzDwh

Related blogpost: bit.ly/4g2zhOR
September 4, 2025 at 7:19 AM
advance-id.bsky.social
✨We’re excited to have Dr Alec Aligui join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
September 3, 2025 at 1:07 AM
advance-id.bsky.social
✨We’re excited to have Dr Bao Qiongling join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
August 27, 2025 at 2:40 AM
advance-id.bsky.social
Big milestone for the Promoting Community Engagement for Clinical Trials in Asia project. We just held our first Scientific Advisory Board Meeting! 🌟 Read more: ad-id.co/cep1
August 19, 2025 at 9:46 AM
advance-id.bsky.social
🚀 Join us in welcoming Dr Iris Chang to the ADVANCE-ID team! Here’s a brief introduction to get to know her better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
July 30, 2025 at 1:16 AM
advance-id.bsky.social
🚀 Join us in welcoming Dr Luca Mezzadri to the ADVANCE-ID team! Here’s a brief introduction to get to know him better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
July 23, 2025 at 6:29 AM
advance-id.bsky.social
We are pleased to announce that earlier this month, we enrolled the first patient into the CRGNB silo of the TREAT-GNB platform trial! TREAT-GNB was also recently initiated at another two hospital centres in China. Read more: ad-id.co/t1
July 22, 2025 at 3:43 AM
advance-id.bsky.social
🚀 Join us in welcoming Dr Abi Manesh to the ADVANCE-ID team! Here’s a brief introduction to get to know him better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
July 16, 2025 at 2:07 AM
advance-id.bsky.social
A new episode in the RESISTALKs podcast series is out! Dive into the BEATLE trial on extended vs bolus β-lactam infusions for febrile neutropenia in haematology patients.

Access the episode here: ad-id.co/4eBkytq

#AMR #RESISTALKs
July 7, 2025 at 10:05 AM
advance-id.bsky.social
✨ We’re excited to share that our Health Economics Interest Group had its very first meet up session yesterday! Thank you to all who joined us as we kicked off a journey into the economics of #InfectiousDiseases & #AMR.

Interested get involved? Drop us an email: mdcmy@nus.edu.sg

#HealthEconomics
June 19, 2025 at 1:38 AM
advance-id.bsky.social
📖 Check out "The AMR Diary" developed by The Antimicrobial Resistance (AMR) Diary team from Universiti Malaya (Malaysia)! This book shines a light on the often-overlooked personal stories behind the global challenge of #AMR.

👉 Read & share: bit.ly/4kHQf6M

#AMRWISE360 #FreeOnlineAccess #AMRDiary
June 12, 2025 at 8:52 AM
advance-id.bsky.social
Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID. 

Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia:
tinyurl.com/infex-advanc...

#infex #ClinicalResearch #AMR
May 21, 2025 at 11:05 AM
advance-id.bsky.social
Today, we join the global community in celebrating #ClinicalTrialsDay, recognising the vital role that clinical trials play in advancing medical science and improving patient care, honoring the power and purpose of all clinical research professionals. #CTD2025 #AMR #ClinicalTrials #GlobalHealth
May 20, 2025 at 1:16 AM